Los Angeles Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.3K Sell
1,281
-245,571
-99% -$2.94M ﹤0.01% 1824
2026
Q1
$1.48M Buy
246,852
+115,300
+88% +$868K 0.01% 576
2025
Q4
$864K Sell
131,552
-72,720
-36% -$575K ﹤0.01% 691
2025
Q3
$2.18M Buy
+204,272
New +$2M 0.01% 481
2025
Q1
– Sell
-85,322
Closed -$1.27M – 1172
2024
Q4
$1.27M Sell
85,322
-174,509
-67% -$2.84M 0.01% 550
2024
Q3
$4.97M Buy
259,831
+83,510
+47% +$1.73M 0.02% 309
2024
Q2
$3.65M Buy
176,321
+6,946
+4% +$138K 0.01% 362
2024
Q1
$3.18M Buy
+169,375
New +$2.91M 0.01% 403
2023
Q1
– Sell
-69,262
Closed -$1.93M – 1262
2022
Q4
$1.93M Sell
69,262
-137,305
-66% -$3.51M 0.01% 521
2022
Q3
$4.83M Sell
206,567
-86,662
-30% -$2.62M 0.03% 367
2022
Q2
$9.9M Sell
293,229
-54,548
-16% -$1.91M 0.05% 278
2022
Q1
$12.1M Buy
347,777
+80,891
+30% +$2.77M 0.05% 257
2021
Q4
$8.13M Sell
266,886
-9,467
-3% -$308K 0.03% 297
2021
Q3
$9.06M Buy
276,353
+185,351
+204% +$5.93M 0.04% 279
2021
Q2
$2.75M Buy
+91,002
New +$3M 0.01% 510

Other funds holding OGN

Los Angeles Capital Management's OGN Position: Q2 2026 in Review

Los Angeles Capital Management reduced its Organon & Co (OGN) stake by 99% in Q2 2026, selling an estimated $2.94M and leaving 1,281 shares worth $17.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1824.

Los Angeles Capital Management first reported a position in OGN in Q2 2021 and has held it in 15 quarters since. The position peaked at $12.1M in Q1 2022. 636 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Los Angeles Capital Management held 1,281 shares of Organon & Co worth $17.3K as of Q2 2026.
  • Los Angeles Capital Management sold 245,571 Organon & Co shares in Q2 2026, an estimated $2.94M.
  • Organon & Co made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1824 holding.
  • Los Angeles Capital Management first reported a position in Organon & Co in Q2 2021 and has held it in 15 quarters since.
  • Los Angeles Capital Management's Organon & Co position peaked at $12.1M in Q1 2022.
  • 636 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.